Tumors expressed the astrocyte marker Gfap, oligodendrocyte lineage and glioma marker Olig2, proliferative marker Ki67, and phosphorylated extracellular kinase (phospho-Erk), indicative of active MAPK pathway signaling (Figures 2E and 2F). This evidence concerns the gene GFAP and central nervous system cancer.